Covid19
Conditions
Brief summary
As an important non-drug intervention in the treatment of respiratory tract diseases, respiratory rehabilitation training is increasingly accepted in clinical practice. The purpose of pulmonary rehabilitation is not only to improve the physical and mental conditions of the patient, but also to help the patient return to the family and society more quickly. In light of the widely documented lung injuries associated with COVID-19, concerns are raised regarding the assessment of lung injury in discharged patients. As an important non-drug intervention in the treatment of respiratory diseases, respiratory rehabilitation training is increasingly being accepted in clinical practice The purpose of pulmonary rehabilitation is not only to improve the physical and mental conditions of the patient, but also to help the patient return to the family and society more quickly. The aim of the study; It is aimed to evaluate the efficiency of breathing exercise in individuals with COVID-19.
Interventions
OTHERBreathing exercise with the phone application
1. Respiratory Control: 2. Pursed Lip Breathing 3. Diaphragmatic Breathing Respiratory exercises will be instructed to the individuals forming the intervention group and participants will be asked to do 3 times a day during one month and the exercises will be done by the researchers together with the individuals by establishing a connection with the phone application (zoom, watsapp) once a week from home.
OTHERBreathing exercise
1. Respiratory Control: 2. Pursed Lip Breathing 3. Diaphragmatic Breathing Breathing exercises will be explained to the control group and visual material will be given. The participants will be asked to do 3 times a day during one month. In terms of physical activity, the patient will be encouraged to participate in the program by suggesting exercises such as walking and cycling at least three times a week for 20 minutes per week
Sponsors
Tokat Gaziosmanpasa University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
Randomised Controlled Study
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 18 years of age or older and who received / will receive treatment with the diagnosis of COVID 19 and completed 2 months after the diagnosis of COVID 19 * Patients who applied to the Pulmonary Diseases outpatient clinic with complaints of dyspnea * FEV1 / FVC \<80%, FVC \<80%, FEV1 \<80%, FEF25-75\> 50% and / or Patients with respiratory distress in daily living activities
Exclusion criteria
* FEV 1 \<50%, FEF 25-75 \<50% detected oxygen saturation \<85% at rest, * moderately severe heart failure, * has a disease that restricts its mobilization, * psychiatric illness, * advanced stage liver, advanced stage renal failure, * Myocardial infarction within 4 months * having a history of unstable angina * active infectious disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 6 minute walking test | 1 month | 6 minute walking test |
| FEV-1 | 1 month | FEV-1 |
| FVC | 1 month | FVC |
| FEV1/FVC | 1 month | FEV1/FVC |
| MVV | 1 month | MVV- Maximal Voluntary Ventilation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| St. George's Respiratory Questionnaire | 1 month | St. George's Respiratory Questionnaire-Scores range from 0 to 100, with higher scores indicating more limitations. |
Countries
Turkey (Türkiye)
Outcome results
None listed